Immune microenvironment of gliomas

Area of Science:

• Neuro-oncology
• Immunology
• Cancer Biology

Background:

• High-grade gliomas are aggressive central nervous system (CNS) tumors with poor prognoses, often resistant to standard treatments.
• The tumor microenvironment (TME) is highly heterogeneous, comprising various immune cells that influence tumor progression.
• Malignant gliomas exhibit a significant infiltration of myeloid cells, including glioma-associated microglia/macrophages (GAMs) and myeloid-derived suppressor cells (MDSCs).

Purpose of the Study:

• To review the immunological landscape of the glioma microenvironment.
• To elucidate the composition and roles of immune cells infiltrating malignant gliomas.
• To understand the mechanisms driving myeloid cell accumulation and reprogramming in gliomas.

Main Methods:

• Histopathological analysis of human and rodent gliomas.
• Flow cytometry to analyze immune cell populations within the tumor.
• Review of existing literature on glioma immunology and TME interactions.

Main Results:

• The density of GAMs and MDSCs in gliomas correlates inversely with patient survival.
• Tumor-reprogrammed GAMs and MDSCs exhibit immunosuppressive functions, hindering anti-tumor immune responses.
• These myeloid cells attract regulatory T cells and inhibit cytotoxic immune cells like NK cells and CD8+ T cells.

Conclusions:

• The glioma microenvironment is profoundly immunosuppressive due to the accumulation and reprogramming of myeloid cells.
• Understanding tumor-derived signals that manipulate immune cells is crucial for developing effective glioma immunotherapies.
• Overcoming immune evasion mechanisms employed by gliomas is a significant challenge for brain tumor immunotherapy.